Related references
Note: Only part of the references are listed.Sprouty proteins: modified modulators, matchmakers or missing links?
G. R. Guy et al.
JOURNAL OF ENDOCRINOLOGY (2009)
SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype
G. Spurlock et al.
JOURNAL OF MEDICAL GENETICS (2009)
The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway
Marie Dance et al.
CELLULAR SIGNALLING (2008)
Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype
Hilde Brems et al.
NATURE GENETICS (2007)
Germline gain-of-function mutations in RAF1 cause Noonan syndrome
M. Abdur Razzaque et al.
NATURE GENETICS (2007)
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy
Bhaswati Pandit et al.
NATURE GENETICS (2007)
Direct binding of PP2A to Sprouty2 and phosphorylation changes are a prerequisite for ERK inhibition downstream of fibroblast growth factor receptor stimulation
Dieu-Hung Lao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Protein tyrosine phosphatase function: the substrate perspective
Tony Tiganis et al.
BIOCHEMICAL JOURNAL (2007)
Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome
Marco Tartaglia et al.
NATURE GENETICS (2007)
Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction
Bruce D. Gelb et al.
HUMAN MOLECULAR GENETICS (2006)
A Src homology 3-binding sequence on the C terminus of Sprouty2 is necessary for inhibition of the Ras/ERK pathway downstream of fibroblast growth factor receptor stimulation
Dieu-Hung Lao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Discovery of a novel Shp2 protein tyrosine phosphatase inhibitor
Liwei Chen et al.
MOLECULAR PHARMACOLOGY (2006)
Sprouty proteins are in vivo targets of Corkscrew/SHP-2 tyrosine phosphatases
LA Jarvis et al.
DEVELOPMENT (2006)
PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects
MI Kontaridis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease
M Tartaglia et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Somatic PTPN11 mutations in childhood acute myeloid leukaemia
M Tartaglia et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Cellular signaling by fibroblast growth factor receptors
VP Eswarakumar et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Activating mutations of the Noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia
M Bentires-Alj et al.
CANCER RESEARCH (2004)
PTPN11 mutations in pediatric patients with acute myeloid leukemia:: results from the Children's Cancer Group
ML Loh et al.
LEUKEMIA (2004)
Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase signaling by dephosphorylating and inactivating the inhibitor sprouty
H Hanafusa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Tyrosyl phosphorylation of Shp2 is required for normal ERK activation in response to some, but not all, growth factors
T Araki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia
M Tartaglia et al.
NATURE GENETICS (2003)
The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
BG Neel et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor
J Schlessinger
CELL (2002)
Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling
ESM Wong et al.
EMBO JOURNAL (2002)
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome
M Tartaglia et al.
NATURE GENETICS (2001)
Identification of a dominant negative mutant of sprouty that potentiates fibroblast growth factor-but not epidermal growth factor-induced ERK activation
A Sasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Spred is a Sprouty-related suppressor of Ras signalling
T Wakioka et al.
NATURE (2001)
Share Paper
